These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 26019801)

  • 1. Expression analysis of CD44 isoforms S and V3, in patients with esophageal squamous cell carcinoma.
    Mansouri A; Foroughmand AM; Abbaszadegan MR; Memar B; Mahmoudian RA; Gholamin M
    Iran J Basic Med Sci; 2015 Apr; 18(4):380-4. PubMed ID: 26019801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced expression of CD44v3 variant isoform is associated with unfavorable outcome in non-small cell lung carcinoma.
    Pirinen R; Hirvikoski P; Böhm J; Kellokoski J; Moisio K; Virén M; Johansson R; Hollmén S; Kosma VM
    Hum Pathol; 2000 Sep; 31(9):1088-95. PubMed ID: 11014576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of CD44 standard, variant isoforms 3 and 6 and -catenin expression in local prostate cancer treated by radical prostatectomy.
    Aaltomaa S; Lipponen P; Viitanen J; Kankkunen JP; Ala-Opas M; Kosma VM
    Eur Urol; 2000 Nov; 38(5):555-62. PubMed ID: 11096236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of CD44 and variant proteins in human colorectal cancer and its relevance for prognosis.
    Ropponen KM; Eskelinen MJ; Lipponen PK; Alhava E; Kosma VM
    Scand J Gastroenterol; 1998 Mar; 33(3):301-9. PubMed ID: 9548625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct CD44 splice variants differentially affect collateral artery growth.
    Bot PT; Grundmann S; van Royen N; Joosten SP; Schirmer SH; de Kleijn DP; Pals ST; Pasterkamp G; Piek JJ; Hoefer IE
    Curr Vasc Pharmacol; 2013 Jan; 11(1):13-20. PubMed ID: 23391418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD44 variant overexpression in gallbladder carcinoma associated with tumor dedifferentiation.
    Yanagisawa N; Mikami T; Mitomi H; Saegusa M; Koike M; Okayasu I
    Cancer; 2001 Jan; 91(2):408-16. PubMed ID: 11180088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced CD44 standard expression is associated with tumour recurrence and unfavourable outcome in differentiated thyroid carcinoma.
    Böhm JP; Niskanen LK; Pirinen RT; Kiraly K; Kellokoski JK; Moisio KI; Eskelinen MJ; Tulla HE; Hollmen S; Alhava EM; Kosma VM
    J Pathol; 2000 Nov; 192(3):321-7. PubMed ID: 11054715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of CD44 standard and isoforms V3 and V6 in uterine smooth muscle tumors: a possible diagnostic tool for the diagnosis of leiomyosarcoma.
    Poncelet C; Walker F; Madelenat P; Bringuier AF; Scoazec JY; Feldmann G; Darai E
    Hum Pathol; 2001 Nov; 32(11):1190-6. PubMed ID: 11727257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of CD44 standard form and variant isoforms in non-small cell lung carcinomas.
    Tran TA; Kallakury BV; Sheehan CE; Ross JS
    Hum Pathol; 1997 Jul; 28(7):809-14. PubMed ID: 9224749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel CD44 v3 isoform is involved in head and neck squamous cell carcinoma progression.
    Franzmann EJ; Weed DT; Civantos FJ; Goodwin WJ; Bourguignon LY
    Otolaryngol Head Neck Surg; 2001 Apr; 124(4):426-32. PubMed ID: 11283501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological associations of CD44 mRNA and protein expression in primary breast carcinomas.
    Berner HS; Suo Z; Risberg B; Villman K; Karlsson MG; Nesland JM
    Histopathology; 2003 Jun; 42(6):546-54. PubMed ID: 12786890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic utility of CD44 standard, CD44v6, and CD44v3-10 expression in adenocarcinomas presenting in serous fluids.
    Afify A; Pang L; Howell L
    Appl Immunohistochem Mol Morphol; 2007 Dec; 15(4):446-50. PubMed ID: 18091389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of CD44 in effusions of patients diagnosed with serous ovarian carcinoma--diagnostic and prognostic implications.
    Berner HS; Davidson B; Berner A; Risberg B; Kristensen GB; Trope CG; Van de Putte G; Nesland JM
    Clin Exp Metastasis; 2000; 18(2):197-202. PubMed ID: 11235996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of CD44s, CD44v3 and CD44v6 in breast cancer.
    Wu XJ; Li XD; Zhang H; Zhang X; Ning ZH; Yin YM; Tian Y
    J Int Med Res; 2015 Apr; 43(2):173-9. PubMed ID: 25571897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of CD44s and CD44 splice variants in human melanoma.
    Ranuncolo SM; Ladeda V; Gorostidy S; Morandi A; Varela M; Lastiri J; Loria D; Del Aguila R; Joffé EB; Pallotta G; Puricelli L
    Oncol Rep; 2002; 9(1):51-6. PubMed ID: 11748454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a Novel Anti-CD44 Monoclonal Antibody for Multiple Applications against Esophageal Squamous Cell Carcinomas.
    Goto N; Suzuki H; Tanaka T; Asano T; Kaneko MK; Kato Y
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD44 variant 6 is involved in the attachment and invasion of endometrial cells to peritoneum.
    Knudtson JF; McLaughlin JE; Sultana M; Santos MT; Sureshkumar MA; Tekmal RR; Schenken RS
    F S Sci; 2020 Nov; 1(2):188-194. PubMed ID: 35559927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-34a suppresses invasion and metastatic in esophageal squamous cell carcinoma by regulating CD44.
    Zuo J; Zhu K; Wang Y; Yu Z
    Mol Cell Biochem; 2018 Jun; 443(1-2):139-149. PubMed ID: 29094237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD44 loss in gastric stromal tumors as a prognostic marker.
    Montgomery E; Abraham SC; Fisher C; Deasel MR; Amr SS; Sheikh SS; House M; Lilliemoe K; Choti M; Brock M; Ephron DT; Zahuruk M; Chadburn A
    Am J Surg Pathol; 2004 Feb; 28(2):168-77. PubMed ID: 15043305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of CD44s and CD44v6 on human breast cancer cell adhesion, migration, and invasion.
    Afify A; Purnell P; Nguyen L
    Exp Mol Pathol; 2009 Apr; 86(2):95-100. PubMed ID: 19167378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.